Physician profile
Brian D Adams
NPI 1982696357
$865,194.02
in general payments reported to CMS, 2019-2025
15 companies · $103K in 2025
The $103K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180K · 2020: $133K · 2021: $145K · 2022: $119K · 2023: $102K · 2024: $82K · 2025: $103K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $272K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,000 · Honoraria: $3,500 · Travel and Lodging: $1,608 · Food and Beverage: $988 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $272,488.31 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,000.00 |
| Honoraria | $3,500.00 |
| Travel and Lodging | $1,607.65 |
| Food and Beverage | $988.34 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $362,311.29 | 2021-2025 | Integra, Integra Spider Limted Wrist Fusion System, Evos |
| Integra Lifesciences Corporation | $282,009.14 | 2019-2021 | |
| Extremity Medical | $175,451.00 | 2019-2025 | Xmcp, Apex |
| Trimed, INC. | $22,120.77 | 2019-2023 | |
| Wright Medical Technology, INC. | $13,473.56 | 2019-2020 | |
| Stryker Corporation | $5,356.15 | 2021-2022 | |
| Xiros INC | $3,594.22 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $320.00 | 2019 | |
| Ascension Orthopedics, INC. | $250.00 | 2020 | |
| Zimmer Biomet Holdings, INC. | $148.20 | 2019-2021 | |
| Depuy Synthes Sales INC. | $79.01 | 2019-2020 | |
| 3m Company | $26.42 | 2019 | |
| Si-Bone, INC. | $22.40 | 2022 | |
| Sanara Medtech INC. | $19.80 | 2021 | |
| Endo Pharmaceuticals INC. | $12.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,662.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.